Both chambers of Congress have now passed a compromise proposal to reform Medicare and add a prescription-drug benefit. How will the pharmaceutical industry, health plans, employers, and consumers respond? At this conference, representatives from the various healthcare sectors affected by the legislation will discuss their perspectives on the bill and its likely impacts.